Chronomodulated chemotherapy versus conventional chemotherapy for advanced colorectal cancer: A meta-analysis of five randomized controlled trials

International Journal of Colorectal Disease

Volumn 25, Issue 3, 2010, Pages 343-350

  Liao, Cun ^a   Li, Jing ^a   Bin, Qiong ^a   Cao, Yunfei ^a   Gao, Feng ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Chronomodulated chemotherapy; Colorectal cancer; Meta analysis

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; META ANALYSIS; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG CHRONOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PUBLICATION BIAS; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649237487     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0838-4     Document Type: Article

References (30)

1. Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0. IARC, Lyon
2. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387
3. HJ Schmoll T Büchele Grothey, et al. 1999 Where do we stand with 5-FU? Semin Oncol 26 589 605 1:CAS:528:DC%2BD3cXivFyqsw%3D%3D 10606252
4. R Von Roemeling WJ Hrushesky 1989 Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer J Clin Oncol 7 1710 1719
5. GC Daher RW Zhang SJ Soong, et al. 1991 Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy Drug Metab Dispos Biol Fate Chem 19 285 287 1:CAS:528:DyaK3MXhslOrsLg%3D 1673417
6. BE Harris R Song SJ Soong, et al. 1989 Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver Cancer Res 49 6610 6614 1:CAS:528:DyaK3cXjtVaisw%3D%3D 2819711
7. Diasio R, Zhang R, Lu Z et al (1992) Circadian variation of fluoropyrimidine metabolic enzymes: importance to fluorodeoxyuridine (FdURD) chemotherapy. In Proceedings of the 5th International Conference on Chronopharmacology, Amelia Island, Fla; abstr IV-1
8. El Kouni M, Naquib F (1992) Circadian rhythm of hepatic pyrimidine metabolizing enzymes and plasma uridine concentration in mice. In Proceedings of the 5th International Conference on Chronopharmacology, Amelia Island, Fla; abstr IV-2
9. Zhang R, Lu E, Liu T et al (1992) Circadian rhythm of rat spleen cytoplasmic thymidine kinase: possible relevance to 5-fluorodeoxyuridine chemotherapy. In Proceedings of the 5th International Conference on Chronopharmacology, Amelia Island, Fla; abstr IV-3
10. M Malmary-Nebot C Labat A Casanovas, et al. 1985 Aspect chronobiologique de l'action du mdthrotrexate sur la dihydrofolate re'ductase Ann Pharm Fr 43 337 343 1:CAS:528:DyaL28XhvF2ktrY%3D 3837620
11. FA Levi R Zidani JM Vannetzel, et al. 1994 Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial J Natl Cancer Inst 86 1608 1617 10.1093/jnci/86.21.1608 1:STN:280:DyaK2M%2FhvVensg%3D%3D 7932825
12. K Mahesh B Parmar V Torri L Stewart 1998 Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Statist Med 17 2815 2834 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID- SIM110>3.0.CO;2-8 (Pubitemid 28562978)
13. AR Jadad RA Moore D Carroll C Jenkinson DJ Reynolds DJ Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 12 10.1016/0197-2456(95)00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D 8721797 (Pubitemid 26120810)
14. LL Kjaergard J Villumsen C Gluud 2001 Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses Ann Intern Med 135 982 989 1:STN:280:DC%2BD3MnovVygsg%3D%3D 11730399
15. D Moher B Pham A Jones DJ Cook AR Jadad M Moher, et al. 1998 Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 609 613 10.1016/S0140-6736(98)01085-X 1:STN:280:DyaK1cvhslWjtg%3D%3D 9746022 (Pubitemid 28380142)
16. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F (2000) Methods for meta-analysis in medical research. Wiley, Chichester
17. CB Begg M Mazumdar 1994 Operating characteristics of a rank correlation test for publication bias Biometrics 50 1088 1101 10.2307/2533446 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D 7786990
18. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563
19. C Garufi B Vanni AM Aschelter AR Zappalà E Bria C Nisticò I Sperduti F Cognetti E Terzoli 2006 Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients Eur J Cancer 42 608 616 10.1016/j.ejca.2005. 03.012 1:CAS:528:DC%2BD28Xit1CitbY%3D 16246545 (Pubitemid 43343682)
20. F Levi R Zidani JL Misset 1997 Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy Lancet 350 681 686 10.1016/S0140-6736(97)03358-8 1:CAS:528:DyaK2sXmt1Oqsb8%3D 9291901 (Pubitemid 27371165)
21. S Giacchetti G Bjarnason C Garufi, et al. 2006 Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group J Clin Oncol 24 3562 3569 10.1200/JCO.2006.06.1440 1:CAS:528:DC%2BD28XovVSjs7k%3D 16877722 (Pubitemid 46630527)
22. RK Ramanathan GA Bjarnason SA Bernard P Desimone T Braich JP Evars WJ Hrushesky J Jolivet 2008 A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer Clin Colorectal Cancer 7 2 134 139 10.3816/CCC.2008.n.018 1:CAS:528:DC%2BD1cXlt1Ckur8%3D 18501073
23. RD Blumenthal C Waskewich DM Goldenberg, et al. 2001 Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts Clin Cancer Res 7 3178 3185 1:CAS:528:DC%2BD3MXnvF2rsrs%3D 11595712
24. F Lévi 2002 From circadian rhythms to cancer chronotherapeutics Chronobiol Int 19 1 19 10.1081/CBI-120002676 11962669 (Pubitemid 34310817)
25. WJ Hrushesky 1985 Circadian timing of cancer chemotherapy Science 228 73 75 10.1126/science.3883493 1:STN:280:DyaL2M7kt1Wkug%3D%3D 3883493
26. F Lévi M Benavides C Chevelle, et al. 1990 Chemotherapy of advanced ovarian cancer with 4-0-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and doseintensity J Clin Oncol 8 705 714 2179481
27. MC Mormont J Waterhouse P Bleuzen, et al. 2000 Marked 24-h rest-activity rhythms are associated with better quality of life, better response and longer survival in patients with metastatic colorectal cancer and good performance status Clin Cancer Res 6 3038 3045 1:STN:280:DC%2BD3M%2FmtVWhsg%3D%3D 10955782
28. SE Sephton RM Sapolsky HC Kraemer, et al. 2000 Diurnal cortisol rhythm as a predictor of breast cancer survival J Natl Cancer Inst 92 994 1000 10.1093/jnci/92.12.994 1:STN:280:DC%2BD3czitV2ntg%3D%3D 10861311
29. R Smaaland OD Laerum RB Sothern, et al. 1992 Colony-forming units-granulocyte-macrophage and DNA synthesis of human bone marrow are circadian stage-dependent and show covariation Blood 79 2281 2287 1:STN:280:DyaK383jvFyrsA%3D%3D 1571543
30. F Levi U Schibler 2007 Circadian rhythms: mechanisms and therapeutic implications Annu Rev Pharmacol Toxicol 47 593 628 10.1146/annurev.pharmtox.47. 120505.105208 1:CAS:528:DC%2BD2sXit1alur4%3D 17209800 (Pubitemid 46272140)